The second publication of Bioethics International's Good Pharma Scorecard, an annual index ranking large pharmaceutical companies and new drugs on their clinical trial transparency, was published in BMJ Open.
Johnson & Johnson and Sanofi, two of eleven ranked companies achievOriginal Article
